Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis

OBJECTIVE: The purpose of this study was to compare the effects of oral hypoglycaemic drugs (HDs) on cognitive function and biomarkers of mild cognitive impairment (MCI) and Alzheimer's disease (AD) through a network meta-analysis of randomized controlled trials (RCTs). METHODS: We conducted sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin-Chen, Chu, Chen-Liang, Li, Han-Cheng, Lu, Kuan, Liu, Cheng-Jiang, Cai, Ye-Feng, Quan, Shi-Jian, Zhang, Shi-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747761/
https://www.ncbi.nlm.nih.gov/pubmed/36530613
http://dx.doi.org/10.3389/fneur.2022.1018027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747761/
https://www.ncbi.nlm.nih.gov/pubmed/36530613
http://dx.doi.org/10.3389/fneur.2022.1018027

Ejemplares similares